Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer

NCT00624182 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Bile Duct Cancer

Interventions

BIOLOGICAL: Peptide vaccine for URLC10
DRUG: Gemcitabine

Sponsor

Akita University Hospital

Collaborators

[object Object]